Ask AI
ProCE Banner Activity

Why Long-Acting ART Works for Me

Clinical Thought

Taking daily HIV pills was hard for me. Pill fatigue, stomach uncertainty, and occasional missed doses made adherence to them stressful. Here, I share my story of switching to long-acting antiretroviral therapy (ART), why it fits my life better, and the impact it has had on me.

Released: February 19, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Target Audience

This activity is intended for United States physicians, pharmacists, nurses, advanced practice providers, and other healthcare professionals who provide antiretroviral therapy for people living with HIV and/or PrEP for people who may benefit from it.

Program Learning Goal

The goal of this activity is to improve healthcare professionals’ competence in adopting LA ART and LA PrEP into routine clinical practice by delivering targeted education that increases awareness of these agents’ clinical value and equips learners with practical strategies for navigating payer requirements, coordinating specialty pharmacy workflows, and integrating injection visits into sustainable care models.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize the value of long-acting antiretroviral therapy and the positive impact it may offer to recipients

Disclosure

Primary Author

Megan E. Dieterich, MPH, MMSc, PA-C: researcher (paid to institution): Gilead, Merck, ViiV.